Furthermore, no differences in percentages of CD8+granzymeB+ cells were observed in splenocytes isolated from vaccinated mice that were not challenged with LLC cells in comparison to vaccinated/tumor challenged mice (Fig. 2C), providing additional evidence that the increased granzyme B response we observe in vaccinated/tumor challenged mice is specific to the cancer cells. The gene discussed is CD8A; the disease is cancer.